Location History:
- Modiin, IL (2017)
- Jerusalem, IL (2017 - 2018)
- Modin, IL (2018)
Company Filing History:
Years Active: 2017-2018
Title: Gila Lithwick Yanai - Innovator in Cancer Prognosis and Classification
Introduction
Gila Lithwick Yanai is an accomplished inventor based in Jerusalem, Israel, known for his significant contributions to cancer research. With a total of four patents to his name, Gila has played a pivotal role in advancing the understanding of ovarian and lung cancers through innovative methodologies and compositions.
Latest Patents
Gila's most recent patents focus on critical advancements in cancer prognosis and classification. One notable patent is titled "Compositions and methods for prognosis of ovarian cancer." This invention describes methods for predicting the prognosis of ovarian cancer subjects and distinguishes between histological subtypes of ovarian cancer tumors. It is particularly significant for its use of microRNA molecules associated with these compositions, offering novel avenues for treatment or prevention of ovarian cancer.
Another key patent, "Methods for lung cancer classification," provides specific nucleic acid sequences for identifying and diagnosing various sub-types of lung cancers. By leveraging microRNA expression profiles obtained from more than two hundred samples, this invention enables accurate classification of lung cancers without the need for additional manipulation.
Career Highlights
Gila has worked with esteemed organizations such as Rosetta Genomics Ltd. and Mor Research Applications Ltd., where he has dedicated his expertise to the field of genomic medicine. His contributions have not only enhanced understanding of cancer biology but have also enabled potential improvements in patient care through accurate diagnostics.
Collaborations
Throughout his career, Gila has collaborated with notable professionals, including Hila Benjamin and Ram Eitan. These collaborations have allowed for a synergistic approach to research, harnessing collective knowledge and diverse skills to drive innovation in cancer treatment and diagnosis.
Conclusion
Gila Lithwick Yanai exemplifies the spirit of innovation in the medical field, particularly in cancer research. His work on cancer prognosis and classification has the potential to impact patient outcomes significantly, demonstrating the importance of continued research and development in this vital area of healthcare. Through his inventions, Gila not only contributes to scientific knowledge but also offers hope to those affected by these challenging diseases.